Sinopharm Group Aktie
2,01
EUR
-0,00
EUR
-0,10
%
2,04
EUR
-0,06
EUR
-2,67
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 5 | 3 | 0 | 138,72 GBP | +22,72% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +40,65% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 0 | 42,00 USD | +66,40% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 8 | 1 | 0 | 111,00 EUR | +37,38% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |